Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
mi
from
Rockville, MD
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Meridian Clinical Research (Rockville Neurology)
mi
from
Rockville, MD
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
mi
from
Las Vegas, NV
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Consortium
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
mi
from
Rochester, NY
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
mi
from
Cleveland, OH
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Rapid Medical Research, Inc.
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated:  12/31/1969
mi
from
Mount Pleasant, SC
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
A Phase III Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (The TEAM Study)
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Little Rock, AR
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Baptist Health Center for Clinical Research
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Long Beach, CA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Riverside, CA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
CI Trials
mi
from
Riverside, CA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Santa Monica, CA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Neurological Research Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
West Palm Beach, FL
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Palm Beach Research
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
New Bedford, MA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
BTC of New Bedford
mi
from
New Bedford, MA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Watertown, MA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
MedVadis Research
mi
from
Watertown, MA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Las Vegas, NV
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Rochester, NY
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Cincinnati, OH
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
CTI Clinical Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Austin, TX
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Neurology and Sleep Lab, LP
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Houston, TX
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Charlottesville, VA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Charlottesville Medical Research Inc.
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Stamford, CT
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
New England Institute for Neurology and Headache (NEINH)/Medical Practice
mi
from
Stamford, CT
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Decatur, GA
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Neurostudies Clinical Research
mi
from
Decatur, GA
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Lauderdale Lakes, FL
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Precision Clinical Research
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Orlando, FL
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solution, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Dallas, TX
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
FutureSearch Trials of Dallas, LP
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Jacksonville, FL
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solution, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Wilmington, NC
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
PMG Research of Wilmington
mi
from
Wilmington, NC
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
North Charleston, SC
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Coastal Carolina Research Center
mi
from
North Charleston, SC
Click here to add this to my saved trials
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Memphis, TN
Study to Determine Safety and Efficacy of B244 in Subjects With Episodic Migraine
A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solution, Inc
mi
from
Memphis, TN
Click here to add this to my saved trials
A Pilot Study of Creative Arts Interventions for Neurology Inpatients
A Pilot Study of Creative Arts Interventions for Neurology Inpatients in the Epilepsy Monitoring Unit and the Headache Service
Status: Enrolling
Updated:  12/31/1969
mi
from
Lebanon, NH
A Pilot Study of Creative Arts Interventions for Neurology Inpatients
A Pilot Study of Creative Arts Interventions for Neurology Inpatients in the Epilepsy Monitoring Unit and the Headache Service
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Prospective ED Headache Cohort Study
Predicting Poor Pain and Functional Outcomes After Discharge From the Emergency Department With a Primary Headache
Status: Enrolling
Updated:  12/31/1969
mi
from
Bronx, NY
Prospective ED Headache Cohort Study
Predicting Poor Pain and Functional Outcomes After Discharge From the Emergency Department With a Primary Headache
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center, 111 East 210th Street
mi
from
Bronx, NY
Click here to add this to my saved trials
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated:  12/31/1969
mi
from
Bronx, NY
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated:  12/31/1969
mi
from
New York, NY
Comparing Naproxen to Sumatriptan for Emergency Headache Patients
A Randomized Clinical Trial to Compare Naproxen and Sumatriptan for Headache Patients Discharged From the Emergency Department (ED)
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Metoclopramide for Migraine: A Dose Finding Study
Metoclopramide for Acute Migraine: A Dose Finding Study
Status: Enrolling
Updated:  12/31/1969
mi
from
Bronx, NY
Metoclopramide for Migraine: A Dose Finding Study
Metoclopramide for Acute Migraine: A Dose Finding Study
Status: Enrolling
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Mindfulness and Migraine Research Study
Mindfulness and Migraine: A Randomized Controlled Trial
Status: Enrolling
Updated:  12/31/1969
mi
from
Palo Alto, CA
Mindfulness and Migraine Research Study
Mindfulness and Migraine: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Palo Alto Medical Foundation Research Institute
mi
from
Palo Alto, CA
Click here to add this to my saved trials
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
Prospective, Randomized, Placebo-controlled, Phase 2 Study of 4-aminopyridine, Atenolol, or Placebo in the Treatment of Patients With Vestibular Migraine
Status: Enrolling
Updated:  12/31/1969
mi
from
Boston, MA
4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
Prospective, Randomized, Placebo-controlled, Phase 2 Study of 4-aminopyridine, Atenolol, or Placebo in the Treatment of Patients With Vestibular Migraine
Status: Enrolling
Updated: 12/31/1969
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Huntsville, AL
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Little Rock, AR
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Walnut Creek, CA
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Boulder, CO
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Palm Beach Gardens, FL
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Palm Beach Gardens, FL
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
South Miami, FL
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Sunrise, FL
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Conyers, GA
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Conyers, GA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Evansville, IN
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Wellesley Hills, MA
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Wellesley Hills, MA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Worcester, MA
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Ann Arbor, MI
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Saint Louis, MO
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Springfield, MO
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Albany, NY
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albany, NY
Click here to add this to my saved trials
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated:  12/31/1969
mi
from
Greensboro, NC
A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 100mg/Day and 300mg/Day Lacosamide for Migraine Prophylaxis.
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials